A Pragmatic Test for Predicting Cognitive Decline
A new study investigates whether combining a simple, remote digital cognitive test with a blood biomarker can better predict cognitive decline in older adults. Researchers measured plasma p-tau217, a known Alzheimer’s disease marker, and a multi-day learning curve (MDLC) from digital tests in 183 cognitively unimpaired participants. The goal was to see if this combined, low-burden approach could improve risk stratification for a major chronic disease.
Continue reading to unlock the full analysis, deeper implications, and why this study may matter for your field.
Unlock Full Briefing — 50% Off with Coupon: ERWMCWYU
Full version includes the complete summary, study significance, and direct link to the original source.
Stay curious. Stay informed — with Science Briefing.
This is a preview briefing. Upgrade to access the full version.
